GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone

Acharjee, 2011, Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS, Brain, 134, 3209, 10.1093/brain/awr242 Antony, 2007, The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes, J Immunol, 179, 1210, 10.4049/jimmunol.179.2.1210 Barbaro Ade, 2002, Block of Stat-1 activation in macrophages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation, Eur J Immunol, 32, 1309, 10.1002/1521-4141(200205)32:5<1309::AID-IMMU1309>3.0.CO;2-4 Belelli, 2005, Neurosteroids: endogenous regulators of the GABA(A) receptor, Nat Rev Neurosci, 6, 565, 10.1038/nrn1703 Bhat, 2010, Inhibitory role for GABA in autoimmune inflammation, Proc Natl Acad Sci U S A, 107, 2580, 10.1073/pnas.0915139107 Carmans, 2013, Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses, J Neuroimmunol, 255, 45, 10.1016/j.jneuroim.2012.11.001 Carter, 1997, Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor, J Pharmacol Exp Ther, 280, 1284 Christiansen, 2007, Cloning and characterization of a functional human gamma-aminobutyric acid (GABA) transporter, human GAT-2, J Biol Chem, 282, 19331, 10.1074/jbc.M702111200 Conti, 1999, Neuronal, glial, and epithelial localization of gamma-aminobutyric acid transporter 2, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in the cerebral cortex and neighboring structures, J Comp Neurol, 409, 482, 10.1002/(SICI)1096-9861(19990705)409:3<482::AID-CNE11>3.0.CO;2-O Conti, 2004, GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications, Brain Res Brain Res Rev, 45, 196, 10.1016/j.brainresrev.2004.03.003 Cordeiro, 2003, Aluminium-induced impairment of Ca2+ modulatory action on GABA transport in brain cortex nerve terminals, J Inorg Biochem, 97, 132, 10.1016/S0162-0134(03)00256-3 Demakova, 2003, Determination of gamma-aminobutyric acid concentration and activity of glutamate decarboxylase in blood serum of patients with multiple sclerosis, Klin Lab Diagn, 15 Deslauriers, 2011, Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration, J Immunol, 187, 4788, 10.4049/jimmunol.1004111 Dionisio, 2011, An intrinsic GABAergic system in human lymphocytes, Neuropharmacology, 60, 513, 10.1016/j.neuropharm.2010.11.007 Eikelenboom, 2002, Neuroinflammation in Alzheimer’s disease and prion disease, Glia, 40, 232, 10.1002/glia.10146 Ellestad, 2009, Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells, J Immunol, 183, 298, 10.4049/jimmunol.0803576 Falkenstein, 2000, Multiple actions of steroid hormones – a focus on rapid, nongenomic effects, Pharmacol Rev, 52, 513 Ferkany, 1978, Measurement of gamma-aminobutyric acid (GABA) in blood, Life Sci, 22, 2121, 10.1016/0024-3205(78)90456-3 Frohman, 2006, Multiple sclerosis – the plaque and its pathogenesis, N Engl J Med, 354, 942, 10.1056/NEJMra052130 Goncalves, 1999, Regulation of the gamma-aminobutyric acid transporter activity by protein phosphatases in synaptic plasma membranes, Neurosci Res, 33, 41, 10.1016/S0168-0102(98)00107-2 Grant, 2006, Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection, J Chromatogr B Analyt Technol Biomed Life Sci, 844, 278, 10.1016/j.jchromb.2006.07.022 Hosie, 2006, Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites, Nature, 444, 486, 10.1038/nature05324 Houtchens, 2007, Pregnancy and multiple sclerosis, Semin Neurol, 27, 434, 10.1055/s-2007-991127 Jorgensen EM (2005), Gaba. WormBook, pp 1–13. LeWitt, 2011, AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial, Lancet Neurol, 10, 309, 10.1016/S1474-4422(11)70039-4 Linhoff, 2001, Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains, Mol Cell Biol, 21, 3001, 10.1128/MCB.21.9.3001-3011.2001 Liptakova, 2000, Effect of ganaxolone on flurothyl seizures in developing rats, Epilepsia, 41, 788, 10.1111/j.1528-1157.2000.tb00244.x Maingat, 2009, Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex, J Neurosci, 29, 8429, 10.1523/JNEUROSCI.5818-08.2009 Mellon, 2008, Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease, Brain Res Rev, 57, 410, 10.1016/j.brainresrev.2007.05.012 Nickerson, 2001, Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity, J Biol Chem, 276, 19089, 10.1074/jbc.M101295200 Nigam, 2010, GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role, Arch Dermatol Res, 302, 507, 10.1007/s00403-010-1052-5 Noorbakhsh, 2006, Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis, J Exp Med, 203, 425, 10.1084/jem.20052148 Noorbakhsh, 2011, Impaired neurosteroid synthesis in multiple sclerosis, Brain, 134, 2703, 10.1093/brain/awr200 Oestreich, 2012, Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors, Nat Rev Immunol, 12, 799, 10.1038/nri3321 Power, 1998, Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients, J Virol, 72, 9045, 10.1128/JVI.72.11.9045-9053.1998 Ram, 2001, A high-performance liquid chromatography-tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma, J Chromatogr B Biomed Sci Appl, 751, 49, 10.1016/S0378-4347(00)00447-3 Reddy, 2010, Neurosteroids: endogenous role in the human brain and therapeutic potentials, Prog Brain Res, 186, 113, 10.1016/B978-0-444-53630-3.00008-7 Reddy, 2010, Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model, Epilepsy Res, 89, 254, 10.1016/j.eplepsyres.2010.01.009 Reddy, 2004, Ganaxolone: a prospective overview, Drugs Future, 29, 227, 10.1358/dof.2004.029.03.793135 Reyes-Garcia, 2007, GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production, J Neuroimmunol, 188, 64, 10.1016/j.jneuroim.2007.05.013 Robel, 1994, Neurosteroids biosynthesis and function, Trends Endocrinol Metab, 5, 1, 10.1016/1043-2760(94)90114-7 Ruiz-Tachiquin, 2002, Gamma-aminobutyric acid transporter (BGT-1) expressed in human astrocytoma U373 MG cells: pharmacological and molecular characterization and phorbol ester-induced inhibition, J Neurosci Res, 69, 125, 10.1002/jnr.10258 Rupprecht, 1997, The neuropsychopharmacological potential of neuroactive steroids, J Psychiatr Res, 31, 297, 10.1016/S0022-3956(96)00060-X Rupprecht, 1993, Progesterone receptor-mediated effects of neuroactive steroids, Neuron, 11, 523, 10.1016/0896-6273(93)90156-L Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 Shiratsuchi, 2009, Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylation, Am J Physiol Cell Physiol, 296, C1400, 10.1152/ajpcell.00345.2008 Soltani, 2011, GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes, Proc Natl Acad Sci U S A, 108, 11692, 10.1073/pnas.1102715108 Soudijn, 2000, The GABA transporter and its inhibitors, Curr Med Chem, 7, 1063, 10.2174/0929867003374363 Stadelmann, 2011, Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications, Curr Opin Neurol, 24, 224, 10.1097/WCO.0b013e328346056f Stuckey, 2005, Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy, J Leukoc Biol, 78, 393, 10.1189/jlb.1203604 Tansey, 2008, Neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy?, Front Biosci, 13, 709, 10.2741/2713 Tian, 2011, Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis, Autoimmunity, 44, 465, 10.3109/08916934.2011.571223 Tsutsui, 2004, A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis, J Neurosci, 24, 1521, 10.1523/JNEUROSCI.4271-03.2004 Vivithanaporn, 2010, Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity, PLoS One, 5, e12856, 10.1371/journal.pone.0012856 Yeh, 2011, Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis, J Immunol, 187, 4998, 10.4049/jimmunol.1100031 Zhu, 2009, CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy, FASEB J, 23, 2928, 10.1096/fj.08-128819